2.2K
Downloads
132
Episodes
The Daily Earnings Reports Podcast is your go-to podcast for the latest corporate financial news. Every trading day, we dive deep into the earnings reports of publicly traded companies, breaking down key metrics, analyzing market reactions, and offering expert insights. Stay informed, make informed investment decisions, and gain a competitive edge in the dynamic world of finance.
Episodes
Tuesday Nov 12, 2024
Tuesday Nov 12, 2024
Key Highlights:
- Revenue: Total revenue for Q3 2024 was $1.862 billion, a slight increase compared to Q3 2023 ($1.831 billion). Net product sales were $1.820 billion, driven primarily by COVID-19 vaccine sales ($1.810 billion), and a small contribution from the newly launched RSV vaccine, mRESVIA ($10 million).
- Net Loss: Moderna reported a net loss of $70 million for Q3 2024, a significant improvement from the $2.012 billion net loss in Q3 2023. This is attributed to decreased operating expenses, particularly in cost of sales.
- Cash Position: Cash and cash equivalents decreased to $1.644 billion as of September 30, 2024, from $2.907 billion at the end of 2023. This is primarily due to investments in marketable securities and a share repurchase program.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.